MRD Tailored Therapy in AML: What We Have Learned So Far by Lok Lam Ngai, Angèle Kelder, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos

Get full text

Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis by Emil ter Veer, Lok Lam Ngai, Gert van Valkenhoef, Nadia Haj Mohammad, Maarten C. J. Anderegg, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven

Get full text

P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML by Jesse Tettero, Yara Buisman, Lok Lam Ngai, Costa Bachas, Bjorn Tore Gjertsen, Angèle Kelder, Arjan van de Loosdrecht, Markus Manz, Thomas Pabst, Willemijn Scholten, Gert Ossenkoppele, Jacqueline Cloos, David de Leeuw

Get full text

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML by Jesse M. Tettero, Yara Buisman, Lok Lam Ngai, Costa Bachas, Bjorn T. Gjertsen, Angèle Kelder, Arjan A. van de Loosdrecht, Markus G. Manz, Thomas Pabst, Willemijn Scholten, Gert J. Ossenkoppele, Jacqueline Cloos, David C. de Leeuw

Get full text

Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis by Jesse M. Tettero, Jesse M. Tettero, Waleed K. W. Al-Badri, Lok Lam Ngai, Lok Lam Ngai, Costa Bachas, Costa Bachas, Dimitri A. Breems, Catharina H. M. J. van Elssen, Thomas Fischer, Bjorn T. Gjertsen, Gwendolyn N. Y. van Gorkom, Patrycja Gradowska, Marjolein J. E. Greuter, Laimonas Griskevicius, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Markus G. Manz, Thomas Pabst, Thomas Pabst, Jakob Passweg, Jakob Passweg, Kimmo Porkka, Bob Löwenberg, Gert J. Ossenkoppele, Gert J. Ossenkoppele, Jeroen J. W. M. Janssen, Jeroen J. W. M. Janssen, Jacqueline Cloos, Jacqueline Cloos

Get full text

P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL by Jesse Tettero, Raffaele Palmieri, Lok Lam Ngai, Costa Bachas, Valentina Arena, Dimitri Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus Manz, Luca Maurillo, Thomas Pabst, Jakob Passweg, Alfonso Piciocchi, Kimmo Porkka, Bob Löwenberg, Adriano Venditti, Gert Ossenkoppele, Francesco Buccisano, Jacqueline Cloos

Get full text

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party by Jesse M. Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B. Walter, Brent L. Wood, Christophe Roumier, Jan Philippé, Barbara Denys, Jeffrey L. Jorgensen, Marie C. Bene, Francis Lacombe, Adriana Plesa, Monica L. Guzman, Agnieszka Wierzbowska, Anna Czyz, Lok Lam Ngai, Adrian Schwarzer, Costa Bachas, Jacqueline Cloos, Marion Subklewe, Michaela Fuering-Buske, Francesco Buccisano

Get full text

P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY. by Lok Lam Ngai, Diana Hanekamp, Angèle Kelder, Willemijn J. Scholten, Jannemieke Carbaat - Ham, Alexander N. Snel, Costa Bachas, Jesse Tettero, Vincent van der Velden, Jennichjen Slomp, Willemijn Hobo, Dimitri Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter Valk, Patrycja Gradowska, Bob Löwenberg, David de Leeuw, Arjan van de Loosdrecht, Gert Ossenkoppele, Jacqueline Cloos

Get full text